# Shanghai Pharmaceuticals > Chinese company **Wikidata**: [Q104876809](https://www.wikidata.org/wiki/Q104876809) **Wikipedia**: [English](https://en.wikipedia.org/wiki/Shanghai_Pharmaceuticals) **Source**: https://4ort.xyz/entity/shanghai-pharmaceuticals ## Summary Shanghai Pharmaceuticals (also known as Shanghai Pharmaceuticals Holding or 上海医药) is a Chinese public company headquartered in China, specializing in pharmaceuticals and founded in 1952. It operates as a publicly traded entity on the Shanghai and Hong Kong stock exchanges. ## Key Facts - Shanghai Pharmaceuticals is a Chinese public company with the unified social credit ID 9131000013358488X7. - It was founded on October 0, 1952. - The company had revenue of 159.0844 billion renminbi in 2018. - It is listed on the Shanghai Stock Exchange (stock code: 601607) and the Hong Kong Stock Exchange. - Its website is http://www.pharm-sh.com.cn. - It has a subsidiary called Xiamen Chinese Medicine Factory. - The company's ISIN is CNE1000012B3. ## FAQs **What is Shanghai Pharmaceuticals?** Shanghai Pharmaceuticals is a Chinese public company specializing in pharmaceuticals, founded in 1952 and listed on the Shanghai and Hong Kong stock exchanges. **What is its revenue?** In 2018, Shanghai Pharmaceuticals reported revenue of 159.0844 billion renminbi. **Where is it headquartered?** The company is headquartered in the People's Republic of China. **What is its stock exchange listing?** Shanghai Pharmaceuticals is listed on the Shanghai Stock Exchange (stock code: 601607) and the Hong Kong Stock Exchange. **What is its website?** The company's official website is http://www.pharm-sh.com.cn. ## Why It Matters Shanghai Pharmaceuticals plays a significant role in China's pharmaceutical industry, contributing to the country's healthcare system by providing pharmaceutical products. As a publicly traded company, it represents a major player in the Chinese capital market, with its operations influencing both the pharmaceutical sector and broader economic development. The company's substantial revenue and stock exchange listings indicate its importance as a major enterprise in China's economy. ## Notable For - Being a major pharmaceutical company in China with significant revenue and market presence. - Operating as a publicly traded entity on both the Shanghai and Hong Kong stock exchanges. - Having a long history dating back to its founding in 1952. - Maintaining a subsidiary, Xiamen Chinese Medicine Factory. - Being recognized globally with presence in multiple languages on Wikipedia. ## Body ### History Shanghai Pharmaceuticals was founded on October 0, 1952, as a Chinese pharmaceutical company. The company has evolved from its initial establishment into a major public enterprise in China's pharmaceutical sector. It has maintained its operations through decades of economic development and market changes. ### Operations and Business The company operates as a public company, offering its securities for sale to the general public through stock exchanges. It specializes in pharmaceutical products and has a subsidiary, Xiamen Chinese Medicine Factory. The company's revenue in 2018 was 159.0844 billion renminbi, indicating its significant scale in the industry. ### Corporate Structure and Governance As a public company, Shanghai Pharmaceuticals is organized as a joint-stock company with distinct ownership and governance structures. The company is owned by shareholders who purchase its publicly traded securities. The corporate governance includes a board of directors elected by shareholders, representing the separation of ownership and control typical of modern corporate structures. ### Market Presence and Listings Shanghai Pharmaceuticals is listed on the Shanghai Stock Exchange (stock code: 601607) and the Hong Kong Stock Exchange. This dual listing allows the company to access capital from both domestic and international markets. The company's stock exchange listings are a key aspect of its operations as a public enterprise. ### Identifiers and Recognition The company has multiple identifiers including its ISIN (CNE1000012B3), unified social credit ID (9131000013358488X7), and KISTI ID (K000229533). It is recognized globally with presence in multiple languages on Wikipedia (English, Russian, and Chinese). The company's sitelink count on Wikipedia is 3, indicating its visibility in the online knowledge ecosystem. ### Subsidiaries and Affiliations The company has at least one subsidiary, Xiamen Chinese Medicine Factory, which operates under its corporate umbrella. This subsidiary contributes to the company's overall pharmaceutical operations and market presence. ### Financial Performance The company reported revenue of 159.0844 billion renminbi in 2018, measured in Chinese renminbi. This financial data is referenced from a financial news source (https://finance.sina.com.cn/zt_d/2019_zq500qbd/). ### Website and Digital Presence The company maintains an official website at http://www.pharm-sh.com.cn, which serves as its primary digital presence for stakeholders and customers. The website provides information about the company's products, services, and corporate information. ### Legal and Regulatory Status As a public company in China, Shanghai Pharmaceuticals operates under Chinese corporate law and regulatory frameworks. The company adheres to the disclosure and reporting standards required for publicly traded entities in China. ## References 1. [Source](https://finance.sina.com.cn/zt_d/2019_zq500qbd/)